Latest News & Features
Americas
The US Court of Appeals for the Federal Circuit has ruled that biosimilar applicants can opt out of the so-called patent dance, paving the way for Sandoz to sell a biosimilar version of an Amgen drug. 22 July 2015
Big Pharma
A new parliamentary group has been created to raise awareness of and help to develop the life sciences industry in the UK. 21 July 2015
Asia
Police in China have reportedly seized 20,000 boxes of counterfeit drugs and detained more than 20 people thought to be selling them online. 20 July 2015
Americas
The US Court of Appeals for the Federal Circuit has upheld a ruling from the Patent Trial and Appeal Board that invalidated three patents owned by Columbia University covering DNA sequencing. 20 July 2015
Americas
Law firm Gowlings has expanded its intellectual property practice by hiring Stephen Ferance as a partner. 20 July 2015
article
Law firm Norton Rose Fulbright has added to its intellectual property practice in New York by hiring Paul Keller as a partner. 17 July 2015
Americas
The Patent Trial and Appeal Board has partly accepted pharmaceutical company Lupin Limited’s petition for an inter partes review of claims in a patent covering a compound that helps to treat HIV. 16 July 2015
Big Pharma
Despite its troubled start, Brazil’s Product Development Partnerships programme is now entering a new stage of its development with the introduction of a more complete system for regulation, but there’s also more scope for patent infringement, say Otto Licks and Ricardo Campello of Licks Attorneys. 16 July 2015
Asia
AstraZeneca has agreed a deal with drug maker Kyowa Hakko Kirin giving the UK pharmaceutical company the option to commercialise an asthma treatment in Japan. 16 July 2015
Americas
Japanese drug maker R-Tech Ueno has sued Apotex for patent infringement after the Canadian-based pharmaceutical company allegedly applied to create a generic version of one of its eye treatment drugs. 15 July 2015